Periodontology Unit, Department of Clinical Research, Eastman Dental Institute, University College London, London, UK.
Clin Oral Implants Res. 2011 Apr;22(4):406-15. doi: 10.1111/j.1600-0501.2010.02094.x. Epub 2011 Feb 8.
The aim of the study was to evaluate new bone formation under etched titanium (SLA) and modified-etched hydrophilic titanium (modSLA) domes placed on the calvarium of healthy, osteoporotic and osteoporotic treated with bisphosphonates rabbits.
Experimental osteoporosis was induced by ovariectomy (OV) and calcium-deficient diet in 24 New Zealand female rabbits. Twelve OV rabbits were treated with weekly dozes of alendronate (Fosamax(®)) (B) while 12 OV rabbits received no treatment (O). Another 12 rabbits were sham operated and used as healthy controls (C). At 6 weeks following OV, one modSLA and one SLA titanium dome were placed in the parietal bones of each rabbit. The animals were sacrificed at 30 and 120 days following the dome placement. Various histomorphometric measurements were performed in the most central of the undecalcified sections produced.
After 30 days of healing, in the C group, the total bone (TB) area was 37.6% and 37.0% under the modSLA and SLA domes, respectively. In the O group, the TB was 35.7% and 24.8%. In the B group, TB was 37.0% and 32.1%, respectively. After 120 days of healing, in the C group TB was 40.1% and 36.4%, respectively. In the O group, TB was 29.6% and 27.9%, respectively. In the B group, TB was 49.7% and 42.5%, respectively. Hierarchical analysis of variance showed that the type of titanium dome significantly influenced new bone and the amount of new bone being in contact with inner surface of the dome (BIC) independently of the observation period and group (P<0.05). The administration of bisphosphonates influenced the BIC (P<0.05).
The use of modSLA surface may promote bone healing and osseointegration in osteoporotic rabbits, whereas administration of bisphosphonates may compromise the osseointegration of the newly formed bone at the early healing period.
本研究旨在评估在健康、骨质疏松和骨质疏松症(接受双膦酸盐治疗)兔的颅骨上放置经蚀刻钛(SLA)和改良蚀刻亲水钛(modSLA)穹顶后新骨的形成情况。
通过卵巢切除术(OV)和低钙饮食在 24 只新西兰雌性兔中诱导实验性骨质疏松症。12 只 OV 兔每周接受阿伦膦酸钠(福善美(®))(B)治疗,而 12 只 OV 兔未接受治疗(O)。另外 12 只兔假手术作为健康对照组(C)。OV 后 6 周,在每只兔的顶骨上放置一个 modSLA 和一个 SLA 钛穹顶。在穹顶放置后 30 和 120 天处死动物。在制备的未脱钙切片中最中央的部分进行各种组织形态计量学测量。
在愈合后 30 天,在 C 组中,modSLA 和 SLA 穹顶下的总骨(TB)面积分别为 37.6%和 37.0%。在 O 组中,TB 为 35.7%和 24.8%。在 B 组中,TB 分别为 37.0%和 32.1%。在愈合后 120 天,在 C 组中,TB 分别为 40.1%和 36.4%。在 O 组中,TB 分别为 29.6%和 27.9%。在 B 组中,TB 分别为 49.7%和 42.5%。层次方差分析显示,钛穹顶的类型独立于观察期和组(P<0.05)显著影响新骨和与穹顶内表面接触的新骨量(BIC)。双膦酸盐的给药影响 BIC(P<0.05)。
使用 modSLA 表面可能促进骨质疏松兔的骨愈合和骨整合,而双膦酸盐的给药可能会在早期愈合期损害新形成骨的骨整合。